You have read all your free articles, to continue reading subscribe to read the rest of this content.
A patent application has been submitted regarding the use of an immunoassay of Thymidine Kinase 1 (TK1) to enable more accurate prognoses in prostate cancer patients. In the study, on which this patent application is based, TK1 protein levels were assayed with AroCell TK 210 ELISA in serum sampleAlready a…
Athera Biotechnologies has announced that two composition of matter patents have been allowed for antibodies with binding to phosphorylcholine, PC. The PC target is part of modified phospholipids and has been characterized as an active driver of vascular inflammation. The therapeutic antibodies cAlready a subscriber Login You have read all…
Follicum has announced that the patent which previously received a Notice of Allowance from the US Patent and Trademark Office has now also been formally approved by the authority. The patent is called "Peptides for Treatment of Diabetes" and the patent will be valid until 2038. The patent coversAlready a…
The Swedish medical image company ContextVision has filed a patent for a new method using high-precision deep learning with digital pathology. The market for their method is estimated to be worth $157 million by 2018. This method allows the company to develop new, unique decision support tools baAlready a subscriber…
